Epilepsy Devices Market
Epilepsy Devices Market Overview
The report is titled as ‘Epilepsy Devices Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the epilepsy devices market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The epilepsy devices market is expected to grow at a significant rate in the near future.
The global epilepsy devices market was valued US$ 7.5 Bn at the end of 2020 and expected to reach at a value of US$ 13.7 Bn by 2028 with a significant CAGR of 7.9%.
Epilepsy Devices Market Definition
Epilepsy can be perceived as a chronic medical condition. Basically, it is a neurological disorder which usually causes frequent unjustifiable seizures, characterized by obscure events of spontaneous movement comprising either a partial part of the body or the entire body. On the other hand, the primary reason for epilepsy is yet unidentified. Some individuals may develop harmful diseases like epilepsy in the wake of strokes, trauma, brain tumors, infections, and birth problems. As per the World Health Organization (WHO), roughly 50 million of the global population is at present affected by epilepsy making it one of the most widely spread neurological disorders across the world.
The medical diagnosis of epilepsy is made through blood tests which comprises the entire blood count, electroencephalograms (EEG), computerized tomography scanning (CT), and magnetic resonance imaging (MRI) in response to the epilepsy symptoms. In addition to that, the numerous therapeutic devices offer new alternatives for the treatment of epilepsy.
Epilepsy Devices Market Dynamics
The massively rising prevalence of epilepsy among the population, especially in geriatric population, across the world is primarily boosting the growth of the global epilepsy devices market. By the same token, the most common cause of epilepsy among the aged masses is the increasing incidence of stroke-related or cryptogenic seizure, followed by tumors and dementia. Owing to which, the epilepsy devices market is projected to grow higher in the years to come.
On top of that, the growing number of technological advancements in the medical devices, therapeutics as well as in the entire healthcare sector, worldwide, is also playing a major role in propelling the growth of the global epilepsy devices market in the near future. In addition to that, the growing degree of awareness among the population regarding the disease and the associated medical devices and treatment process is also positively fueling the growth of the global epilepsy devices market in the forthcoming future.
However, the diagnosis and medical treatment of diseases like epilepsy might cost higher which is likely to hold back the growth of the global epilepsy devices market over the forecast period. Nevertheless, the rising funding for the research and development activities in epilepsy is yet expected to boost the growth of the global epilepsy devices market in the coming years.
Epilepsy Devices Market Segmentation
The global epilepsy devices market is segmented on the basis of product type, end-user, and region. The product type segment of the epilepsy devices market is divided into Vagus Nerve Stimulator, Responsive Neurostimulation. Furthermore, the end-user segment is divided into Hospitals & Clinics, Ambulatory Surgical Centers, Neurology Centers, Homecare Settings, Others.
Epilepsy Devices Market Key Players
The global epilepsy devices market is dominated by Cerbomed GmbH, electroCore, Inc., Cyberonics, Inc., NeuroPace, Inc., Boston Scientific Corporation, Medtronic plc,, among others.
MMC Overview on Epilepsy Devices Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the epilepsy devices market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of epilepsy devices
Advantages of epilepsy devices
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
Epilepsy Devices Market Overview
The report is titled as ‘Epilepsy Devices Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the epilepsy devices market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The epilepsy devices market is expected to grow at a significant rate in the near future.
The global epilepsy devices market was valued US$ 7.5 Bn at the end of 2020 and expected to reach at a value of US$ 13.7 Bn by 2028 with a significant CAGR of 7.9%.
Epilepsy Devices Market Definition
Epilepsy can be perceived as a chronic medical condition. Basically, it is a neurological disorder which usually causes frequent unjustifiable seizures, characterized by obscure events of spontaneous movement comprising either a partial part of the body or the entire body. On the other hand, the primary reason for epilepsy is yet unidentified. Some individuals may develop harmful diseases like epilepsy in the wake of strokes, trauma, brain tumors, infections, and birth problems. As per the World Health Organization (WHO), roughly 50 million of the global population is at present affected by epilepsy making it one of the most widely spread neurological disorders across the world.
The medical diagnosis of epilepsy is made through blood tests which comprises the entire blood count, electroencephalograms (EEG), computerized tomography scanning (CT), and magnetic resonance imaging (MRI) in response to the epilepsy symptoms. In addition to that, the numerous therapeutic devices offer new alternatives for the treatment of epilepsy.
Epilepsy Devices Market Dynamics
The massively rising prevalence of epilepsy among the population, especially in geriatric population, across the world is primarily boosting the growth of the global epilepsy devices market. By the same token, the most common cause of epilepsy among the aged masses is the increasing incidence of stroke-related or cryptogenic seizure, followed by tumors and dementia. Owing to which, the epilepsy devices market is projected to grow higher in the years to come.
On top of that, the growing number of technological advancements in the medical devices, therapeutics as well as in the entire healthcare sector, worldwide, is also playing a major role in propelling the growth of the global epilepsy devices market in the near future. In addition to that, the growing degree of awareness among the population regarding the disease and the associated medical devices and treatment process is also positively fueling the growth of the global epilepsy devices market in the forthcoming future.
However, the diagnosis and medical treatment of diseases like epilepsy might cost higher which is likely to hold back the growth of the global epilepsy devices market over the forecast period. Nevertheless, the rising funding for the research and development activities in epilepsy is yet expected to boost the growth of the global epilepsy devices market in the coming years.
Epilepsy Devices Market Segmentation
The global epilepsy devices market is segmented on the basis of product type, end-user, and region. The product type segment of the epilepsy devices market is divided into Vagus Nerve Stimulator, Responsive Neurostimulation. Furthermore, the end-user segment is divided into Hospitals & Clinics, Ambulatory Surgical Centers, Neurology Centers, Homecare Settings, Others.
Epilepsy Devices Market Key Players
The global epilepsy devices market is dominated by Cerbomed GmbH, electroCore, Inc., Cyberonics, Inc., NeuroPace, Inc., Boston Scientific Corporation, Medtronic plc,, among others.
MMC Overview on Epilepsy Devices Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the epilepsy devices market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of epilepsy devices
Advantages of epilepsy devices
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Epilepsy Devices Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Epilepsy Devices Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Epilepsy Devices Market Snapshot
2.4. Global Epilepsy Devices Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Epilepsy Devices Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Porter’s Five Forces Model
2.7. SWOT Analysis
3. Epilepsy Devices Assessment and Analysis
3.1. Epilepsy Devices Impact Analysis
3.2. Actions to encourage use of Epilepsy Devices
3.3. Epilepsy Devices Promotional Strategy Recommendation
3.4. Road Map Analysis
3.5. GAP Analysis
3.6. Potential Analysis
4. Covid-19 Impact on Epilepsy Devices Market
5. Global Epilepsy Devices Market, By Product Type
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Product Type
5.1.2. BPS Analysis, By Product Type
5.2. Market Revenue (US$ Mn) and Forecast, By Product Type
5.2.1. Vagus Nerve Stimulator
5.2.2. Responsive Neurostimulation
5.3. Global Epilepsy Devices Market Attractiveness Index, By Product Type
6. Global Epilepsy Devices Market, By End-Users
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By End-Users
6.1.2. BPS Analysis, By End-Users
6.2. Market Revenue (US$ Mn) and Forecast, By End-Users
6.2.1. Hospitals & Clinics
6.2.2. Ambulatory Surgical Centers
6.2.3. Neurology Centers
6.2.4. Homecare Settings
6.2.5. Others
6.3. Global Epilepsy Devices Market Attractiveness Index, By End-Users
7. Global Epilepsy Devices Market, By Region
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Region
7.1.2. BPS Analysis, By Region
7.2. Market Revenue (US$ Mn) and Forecast, By Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Europe
7.2.4. Asia Pacific
7.2.5. Middle East
7.2.6. Africa
7.3. Global Epilepsy Devices Market Attractiveness Index, By Region
8. North America Epilepsy Devices Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$ Mn) and Forecast, By Country
8.2.1. U.S. Epilepsy Devices Market
8.2.2. Canada Epilepsy Devices Market
8.3. North America Epilepsy Devices Market, By Product Type
8.3.1. Vagus Nerve Stimulator
8.3.2. Responsive Neurostimulator
8.4. North America Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users
8.4.1. Hospitals & Clinics
8.4.2. Ambulatory Surgical Centers
8.4.3. Neurology Centers
8.4.4. Homecare Settings
8.4.5. Others
8.5. North America Epilepsy Devices Market Attractiveness Index
8.5.1. By Country
8.5.2. By Product Type
8.5.3. By End-Users
9. Latin America Epilepsy Devices Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$ Mn) Forecast, By Country
9.2.1. Brazil Epilepsy Devices Market
9.2.2. Mexico Epilepsy Devices Market
9.2.3. Rest of Latin America Epilepsy Devices Market
9.3. Latin America Epilepsy Devices Market, By Product Type
9.3.1. Vagus Nerve Stimulator
9.3.2. Responsive Neurostimulator
9.4. Latin America Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users
9.4.1. Hospitals & Clinics
9.4.2. Ambulatory Surgical Centers
9.4.3. Neurology Centers
9.4.4. Homecare Settings
9.4.5. Others
9.5. Latin America Epilepsy Devices Market Attractiveness Index
9.5.1. By Country
9.5.2. By Product Type
9.5.3. By End-Users
10. Europe Epilepsy Devices Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$ Mn) Forecast, By Country
10.2.1. U.K. Epilepsy Devices Market
10.2.2. Germany Epilepsy Devices Market
10.2.3. Italy Epilepsy Devices Market
10.2.4. France Epilepsy Devices Market
10.2.5. Spain Epilepsy Devices Market
10.2.6. Russia Epilepsy Devices Market
10.2.7. Rest of Europe Epilepsy Devices Market
10.3. Europe Epilepsy Devices Market, By Product Type
10.3.1. Vagus Nerve Stimulator
10.3.2. Responsive Neurostimulator
10.4. Europe Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users
10.4.1. Hospitals & Clinics
10.4.2. Ambulatory Surgical Centers
10.4.3. Neurology Centers
10.4.4. Homecare Settings
10.4.5. Others
10.5. Europe Epilepsy Devices Market Attractiveness Index
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By End-Users
11. Asia Pacific Epilepsy Devices Market Analysis and Forecast, 2020–2028
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$ Mn) Forecast, By Country
11.2.1. China Epilepsy Devices Market
11.2.2. India Epilepsy Devices Market
11.2.3. Japan Epilepsy Devices Market
11.2.4. Australia and New Zealand Epilepsy Devices Market
11.2.5. South Korea Epilepsy Devices Market
11.2.6. Rest of Asia Pacific Epilepsy Devices Market
11.3. Asia Pacific Epilepsy Devices Market, By Product Type
11.3.1. Vagus Nerve Stimulator
11.3.2. Responsive Neurostimulator
11.4. Asia Pacific Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users
11.4.1. Hospitals & Clinics
11.4.2. Ambulatory Surgical Centers
11.4.3. Neurology Centers
11.4.4. Homecare Settings
11.4.5. Others
11.5. Asia Pacific Epilepsy Devices Market Attractiveness Index
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By End-Users
12. Middle East Epilepsy Devices Market Analysis and Forecast, 2020–2028
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$ Mn) Forecast, By Country
12.2.1. GCC Countries Epilepsy Devices Market
12.2.2. Israel Epilepsy Devices Market
12.2.3. Rest of Middle East Epilepsy Devices Market
12.3. Middle East Epilepsy Devices Market, By Product Type
12.3.1. Vagus Nerve Stimulator
12.3.2. Responsive Neurostimulator
12.4. Middle East Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users
12.4.1. Hospitals & Clinics
12.4.2. Ambulatory Surgical Centers
12.4.3. Neurology Centers
12.4.4. Homecare Settings
12.4.5. Others
12.5. Middle East Epilepsy Devices Market Attractiveness Index
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By End-Users
13. Africa Epilepsy Devices Market Analysis and Forecast, 2020–2028
13.1. Introduction
13.1.1. Annual Growth Rate Comparison, By Country
13.1.2. BPS Analysis, By Country
13.2. Market (US$ Mn) Forecast, By Country
13.2.1. South Africa Countries Epilepsy Devices Market
13.2.2. Egypt Epilepsy Devices Market
13.2.3. North Africa Epilepsy Devices Market
13.2.4. Rest of Africa Epilepsy Devices Market
13.3. Africa Epilepsy Devices Market, By Product Type
13.3.1. Vagus Nerve Stimulator
13.3.2. Responsive Neurostimulator
13.4. Africa Epilepsy Devices Market Revenue (US$ Mn) and Forecast, By End-Users
13.4.1. Hospitals & Clinics
13.4.2. Ambulatory Surgical Centers
13.4.3. Neurology Centers
13.4.4. Homecare Settings
13.4.5. Others
13.5. Africa Epilepsy Devices Market Attractiveness Index
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By End-Users
14. Competitive Landscape
14.1. Company Profiles
14.1.1. Cerbomed GmbH
14.1.1.1. Company Overview
14.1.1.2. Financial Overview
14.1.1.3. Key Developments
14.1.1.4. Strategies
14.1.1.5. Product Portfolio
14.1.2. electroCore Inc.
14.1.3. Cyberonics Inc.
14.1.4. NeuroPace Inc.
14.1.5. Boston Scientific Corporation
14.1.6. Medtronic plc.
15. Acronyms